Article(id=1330225302808146821, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225302346773381, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2022.04.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1644854400000, receivedDateStr=2022-02-15, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795080026580, onlineDateStr=2026-11-19, pubDate=1649520000000, pubDateStr=2022-04-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795080026580, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795080026580, creator=13701087609, updateTime=1795080026580, updator=13701087609, issue=Issue{id=1330225302346773381, tenantId=1146029695717560320, journalId=1319690329412173987, year='2022', volume='43', issue='4', pageStart='347', pageEnd='484', issueExtLink='null', onlineDate='null', pubDate='1649520000000', pubDateStr='2022-04-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795080026470, creator='13701087609', updateTime=1795084707533, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330244936621994666, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225302346773381, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330244936621994667, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225302346773381, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=347, endPage=351, ext={EN=ArticleExt(id=1330225304490062727, articleId=1330225302808146821, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Updated key points and interpretation of the Sixth International Consensus Conference for Advanced Breast Cancer focusing on the hormone receptor positive subtype, columnId=1326652874119033612, journalTitle=World Clinical Drug, columnName=Recommendation, runingTitle=null, highlight=null, articleAbstract=
The International Consensus Conference for Advanced Breast Cancer (ABC) is a premier international conference in breast cancer field organized by European School of Oncology (ESO) and European Society for Medical Oncology (ESMO). The conference aims to develop international consensus guidelines for the management of ABC patients, affect treatment decisions, prolong patients' overall survival, and improve patients' quality of life based on the latest evidence-based medical solutions. Breast cancer is divided into different subtypes on different hormone receptor (HR) and human epidermal growth factor receptor-2 (HER2) status. HR positive/HER2 negative breast cancer is the most common. With the emergence of various novel candidates for endocrine and targeted therapies, optimal drug selection and appropriate arrangement is critical to the prolongation of patients' survival. November 2021, the Sixth International Consensus Conference for ABC was successfully held online, which provided guidance for the clinical practice. The article reviewed the updated key points and interpretation of HR positive/HER2 negative ABC part, in order to provide reference for the medication of ABC patients.
, authors=Shuhui JU, Hengyu LI
*, authorsList=Shuhui JU, Hengyu LI, authorCompany=null, correspAuthors=Hengyu LI, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330225304729138056, articleId=1330225302808146821, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=第6届晚期乳腺癌国际共识会议对激素受体阳性晚期乳腺癌的更新要点及解读, columnId=1326652874295194382, journalTitle=世界临床药物, columnName=本期推荐, runingTitle=null, highlight=null, articleAbstract=
晚期乳腺癌(advanced breast cancer,ABC)国际共识会议是由欧洲肿瘤学院(European School of Oncology,ESO)联合欧洲肿瘤内科学会(European Society for Medical Oncology,ESMO)举办的乳腺癌学术领域重要的国际性会议。会议基于最新的循证医学证据,为ABC患者的管理制定国际共识指南,旨在影响治疗决策、延长患者生命及提高患者生活质量。根据不同激素受体(hormone receptor,HR)和人类表皮生长因子受体-2(human epidermal growth factor receptor-2,HER2)状态,乳腺癌被分为不同的分子分型,其中HR阳性/HER2阴性乳腺癌最为常见。随着内分泌治疗和靶向治疗等多种新型治疗药物的涌现,如何选择治疗药物、怎样做好治疗策略优化是为晚期患者带来生存获益的关键。2021年11月,第6届ABC国际共识会议已于线上成功召开,为临床实践提供了指导。该文对会议中HR阳性/HER2阴性ABC领域相关内容更新及投票结果进行解读,以期为ABC患者用药提供参考。
, authors=巨淑慧, 李恒宇
*, authorsList=巨淑慧, 李恒宇, authorCompany=null, correspAuthors=李恒宇, authorNote=
巨淑慧,住院医师,硕士研究生,研究方向:甲状腺与乳腺肿瘤综合治疗。
, correspAuthorsNote=
李恒宇,副教授,副主任医师,研究方向:乳腺癌综合治疗。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=pHcuYIRxXS28KpHXIVHAYQ==, magXml=teyMXknazvsfOmVyhKdhiA==, pdfUrl=null, pdf=0gkV+nJvjZ2TGi8Noi2/kA==, pdfFileSize=1598306, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=DcZ4y3HtGq0XnE5ehMhThA==, mapNumber=null, fund=null)}, authors=[Author(id=1330225305047905165, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225305123402639, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, authorId=1330225305047905165, language=EN, stringName=Shuhui JU, firstName=Shuhui, middleName=null, lastName=JU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Thyroid and Breast Surgery, Changhai Hospital, Navy Medical University, Shanghai 200433, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225305190511504, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, authorId=1330225305047905165, language=CN, stringName=巨淑慧, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=海军军医大学附属长海医院甲状腺乳腺外科,上海 200433, bio={"content":"
巨淑慧,住院医师,硕士研究生,研究方向:甲状腺与乳腺肿瘤综合治疗。
"}, bioImg=null, bioContent=
巨淑慧,住院医师,硕士研究生,研究方向:甲状腺与乳腺肿瘤综合治疗。
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225304959824777, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, xref=null, ext=[AuthorCompanyExt(id=1330225304968213386, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, companyId=1330225304959824777, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Thyroid and Breast Surgery, Changhai Hospital, Navy Medical University, Shanghai 200433, China), AuthorCompanyExt(id=1330225304980796299, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, companyId=1330225304959824777, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=海军军医大学附属长海医院甲状腺乳腺外科,上海 200433)])]), Author(id=1330225305245037458, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225305366672276, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, authorId=1330225305245037458, language=EN, stringName=Hengyu LI, firstName=Hengyu, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=Department of Thyroid and Breast Surgery, Changhai Hospital, Navy Medical University, Shanghai 200433, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225305437975445, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, authorId=1330225305245037458, language=CN, stringName=李恒宇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=海军军医大学附属长海医院甲状腺乳腺外科,上海 200433, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225304959824777, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, xref=null, ext=[AuthorCompanyExt(id=1330225304968213386, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, companyId=1330225304959824777, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Thyroid and Breast Surgery, Changhai Hospital, Navy Medical University, Shanghai 200433, China), AuthorCompanyExt(id=1330225304980796299, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, companyId=1330225304959824777, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=海军军医大学附属长海医院甲状腺乳腺外科,上海 200433)])])], keywords=[Keyword(id=1330225305526055830, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, language=EN, orderNo=1, keyword=breast cancer), Keyword(id=1330225305605747607, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, language=EN, orderNo=2, keyword=hormone receptor positive), Keyword(id=1330225305660273560, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, language=EN, orderNo=3, keyword=human epidermal growth factor receptor-2 negative), Keyword(id=1330225305723188121, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, language=EN, orderNo=4, keyword=the International Consensus Conference for Advanced Breast Cancer), Keyword(id=1330225305781908378, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, language=EN, orderNo=5, keyword=CDK4/6 inhibitor), Keyword(id=1330225305840628635, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, language=CN, orderNo=1, keyword=乳腺癌), Keyword(id=1330225305916126108, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, language=CN, orderNo=2, keyword=激素受体阳性), Keyword(id=1330225305995817885, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, language=CN, orderNo=3, keyword=人类表皮生长因子受体-2阴性), Keyword(id=1330225306100675486, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, language=CN, orderNo=4, keyword=晚期乳腺癌国际共识会议), Keyword(id=1330225306163590047, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, language=CN, orderNo=5, keyword=CDK4/6抑制剂)], refs=[Reference(id=1330225306251670432, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=张金凤, 胡夕春. 激素受体阳性转移性乳腺癌的内分泌治疗[J]. 中华肿瘤杂志, 2015, 37(12): 881-884., articleTitle=null, refAbstract=null), Reference(id=1330225306314584993, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=ESO, EMSO. Advanced Breast Cancer 6
th International Consensus Conference[EB/OL]. [2022-02-01]. http://www.lingyuint.com/2022/2022_abc.html., articleTitle=null, refAbstract=null), Reference(id=1330225306373305250, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Lu YS, Im SA, Colleoni M,
et al. Updated overall survival of ribociclib plus endocrine therapy versus endocrine therapy alone in pre- and perimenopausal patients with HR
+/HER2
- advanced breast cancer in MONALEESA-7: a phase Ⅲrandomized clinical trial[J]. Clin Cancer Res, 2022, 28(5): 851-859., articleTitle=null, refAbstract=null), Reference(id=1330225306432025507, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Johnston S, Martin M, Leo AD,
et al. MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer[J]. NPJ Breast Cancer, 2019, 5: 5., articleTitle=null, refAbstract=null), Reference(id=1330225306490745764, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Rugo HS, Finn RS, Diéras V,
et al. Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up[J]. Breast Cancer Res Treat, 2019, 174(3): 719-729., articleTitle=null, refAbstract=null), Reference(id=1330225306566243237, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Braal CL, Jongbloed EM, Wilting SM,
et al. Inhibiting CDK4/6 in breast cancer with palbociclib, ribociclib, and abemaciclib: similarities and differences[J]. Drugs, 2021, 81(3): 317-331., articleTitle=null, refAbstract=null), Reference(id=1330225306641740710, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Chen P, Lee NV, Hu W,
et al. Spectrum and degree of CDK drug interactions predicts clinical performance[J]. Mol Cancer Ther, 2016, 15(10): 2273-2281., articleTitle=null, refAbstract=null), Reference(id=1330225306700460968, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Martin M, Zielinski C, Ruiz-Borrego M,
et al. Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase Ⅲ randomised controlled trial-PEARL[J]. Ann Oncol, 2021, 32(4): 488-499., articleTitle=null, refAbstract=null), Reference(id=1330225306780152746, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Park YH, Kim TY, Kim GM,
et al. Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial[J]. Lancet Oncol, 2019, 20(12): 1750-1759., articleTitle=null, refAbstract=null), Reference(id=1330225306847261611, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=André F, Ciruelos E, Rubovszky G,
et al. Alpelisib for
PIK3CA-mutated, hormone receptor-positive advanced breast cancer[J]. N Engl J Med, 2019, 380(20): 1929-1940., articleTitle=null, refAbstract=null), Reference(id=1330225306914370476, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=André F, Ciruelos EM, Juric D,
et al. Alpelisib plus fulvestrant for
PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: final overall survival results from SOLAR-1[J]. Ann Oncol, 2021, 32(2): 208-217., articleTitle=null, refAbstract=null), Reference(id=1330225306977285037, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Rugo HS, Lerebours F, Ciruelos E,
et al. Alpelisib plus fulvestrant in
PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study[J]. Lancet Oncol, 2021, 22: 489-498., articleTitle=null, refAbstract=null), Reference(id=1330225307040199598, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Yardley DA, Noguchi S, Pritchard KI,
et al. Everolimus plus exemestane in postmenopausal patients with HR(+) breast cancer: BOLERO-2 final progression-free survival analysis[J]. Adv Ther, 2013, 30(10): 870-884., articleTitle=null, refAbstract=null), Reference(id=1330225307098919855, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Piccart M, Hortobagyi GN, Campone M,
et al. Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2[J]. Ann Oncol, 2014, 25(12): 2357-2362., articleTitle=null, refAbstract=null), Reference(id=1330225307161834416, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Jiang Z, Li W, Hu X,
et al. Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial[J]. Lancet Oncol, 2019, 20(6): 806-815., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330225304959824777, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, xref=null, ext=[AuthorCompanyExt(id=1330225304968213386, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, companyId=1330225304959824777, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Thyroid and Breast Surgery, Changhai Hospital, Navy Medical University, Shanghai 200433, China), AuthorCompanyExt(id=1330225304980796299, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225302808146821, companyId=1330225304959824777, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=海军军医大学附属长海医院甲状腺乳腺外科,上海 200433)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.04.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.04.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2022.04.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2022.04.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1649520000000, fullTextJson=null, articleText=null, reference=null)